SB-245570
SB-245570 is a serotonin 5-HT 1B receptor antagonist which was under development for the treatment of major depressive disorder but was never marketed.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
SB-245570 is a serotonin 5-HT 1B receptor antagonist which was under development for the treatment of major depressive disorder but was never marketed. It was being developed by GlaxoSmithKline in the 1990s. A chemical synthesis for SB-245570 has been published. The drug reached the preclinical research stage of development prior to the discontinuation of its development.
See also
List of investigational antidepressants
Text derived from https://en.wikipedia.org/w/index.php?oldid=1328696146 under CC BY-SA 4.0; modifications have been made.